Role of oxygen in postischemic myocardial injury

Antioxidants and Redox Signaling

Volumn 9, Issue 8, 2007, Pages 1193-1206

  Kutala, Vijay Kumar ^a   Khan, Mahmood ^a   Angelos, Mark G ^a   Kuppusamy, Periannan ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; FIBRINOLYTIC AGENT; OXYGEN; OXYGEN RADICAL;

APOPTOSIS; CELL DEATH; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; ELECTROPHYSIOLOGY; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HUMAN; LEUKOCYTE ACTIVATION; MORPHOLOGY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SURVIVAL; SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; ANOXIA; APOPTOSIS; FREE RADICALS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; OXYGEN; OXYGEN INHALATION THERAPY; REPERFUSION INJURY; TIME FACTORS;

EID: 34447532251     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1636     Document Type: Review

References (172)

1. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Zhu W, Kadowaki T, and Yazaki Y. Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes. Circ Res 84: 458-466, 1999.
2. Ambrosio G and Chiariello M. Metabolic changes and their mechanical consequences in acute myocardial ischemia. Cardiologia 36: 379-387, 1991.
3. Ambrosio G, Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M, Chiariello M, and Flaherty JT. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem 268: 18532-18541, 1993.
4. Amrani M, Chester AH, Jayakumar J, Schyns CJ, and Yacoub MH. L-Arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function. Cardiovasc Res 30: 200-204, 1995.
5. Angelos MG, Kutala VK, Torres CA, He G, Stoner JD, Mohammad M, and Kuppusamy P. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am J Physiol Heart Circ Physiol 290: H341-H347, 2006.
6. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, and Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 93(suppl 3): 8-12, 1998.
7. Armstrong SC. Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res 61: 427-436, 2004.
8. Bagchi D, Wetscher GJ, Bagchi M, Hinder PR, Perdikis G, Stohs SJ, Hinder RA, and Das DK. Interrelationship between cellular calcium homeostasis and free radical generation in myocardial reperfusion injury. Chem Biol Interact 104: 65-85, 1997.
9. Beard T, Carrie D, Boyer MJ, Boudjemaa B, Ferrieres J, Delay M, Bernadet P, and Thouvenot JP. [Production of oxygen free radicals in myocardial infarction treated by thrombolysis: analysis of glutathione peroxidase, superoxide dismutase and malondialdehyde]. Arch Mal Coeur Vaiss 87: 1289-1296, 1994.
10. Becker L and Ambrosio G. Myocardial consequences of reperfusion. Prog Cardiovasc Dis 30: 23-44, 1987.
11. Beckman JS and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271: C1424-C1437, 1996.
12. Bertuglia S and Giusti A. Role of nitric oxide in capillary perfusion and oxygen delivery regulation during systemic hypoxia. Am J Physiol Heart Circ Physiol 288: H525-H531, 2005.
13. Bolli R. Causative role of oxyradicals in myocardial stunning: a proven hypothesis: a brief review of the evidence demonstrating a major role of reactive oxygen species in several forms of postischemic dysfunction. Basic Res Cardiol 93: 156-162, 1998.
14. Bolli R. Role of neutrophils in myocardial stunning after brief ischaemia: the end of a six year old controversy (1987-1993). Cardiovasc Res 27: 728-730, 1993.
15. Bolli R, Bhatti ZA, Tang XL, Qiu Y, Zhang Q, Guo Y, and Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42-52, 1997.
16. Bolli R, Jeroudi MO, Patel BS, Aruoma OI, Halliwell B, Lai EK, and McCay PB. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res 65: 607-622, 1989.
17. Bolli R and Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999.
18. Bratasz A, Weir NM, Parinandi NL, Zweier JL, Sridhar R, Ignarro LJ, and Kuppusamy P. Reversal of cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. Proc Natl Acad Sci U S A 103: 3914-3919, 2006.
19. Braunwald E and Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66: 1146-1149, 1982.
20. Brown JM, Terada LS, Grosso MA, Whitmann GJ, Velasco SE, Patt A, Harken AH, and Repine JE. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest 81: 1297-1301, 1988.
21. Buckberg GD. Myocardial protection: an overview. Semin Thorac Cardiovasc Surg 5: 98-106, 1993.
22. Buckberg GD. Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. J Thorac Cardiovasc Surg 93: 127-139, 1987.
23. Buras JA, Stahl GL, Svoboda KK, and Reenstra WR. Hyperbaric oxygen downregulates ICAM-1 expression induced by hypoxia and hypoglycemia: the role of NOS. Am J Physiol Cell Physiol 278: C292-C302, 2000.
24. Burkoff D and Lefer DJ. Cardioprotection before revascularization in ischemic myocardial injury and the potential role of hemoglobin-based oxygen carriers. Am Heart J 149: 573-579, 2003.
25. Carini M, Aldini G, Orioli M, and Maffei Facino R. In vitro metabolism of a nitroderivative of acetylsalicylic acid (NCX4016) by rat liver: LC and LC-MS studies. J Pharm Biomed Anal 29: 1061-1071, 2002.
26. Carini M, Aldini G, Stefani R, Orioli M, and Facino RM. Nitrosylhemoglobin, an unequivocal index of nitric oxide release from nitroaspirin: in vitro and in vivo studies in the rat by ESR spectroscopy. J Pharm Biomed Anal 26: 509-518, 2001.
27. Carla BS, Brian AC, Anne FH, and Roberts FH. Hyperoxemic reperfusion does not increase myocardial infarct size. Am J Physiol 260: H1307-H1312, 1991.
28. Chen Z, Oberley TD, Ho Y, Chua CC, Siu B, Hamdy RC, Epstein CJ, and Chua BH. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med 29: 589-596, 2000.
29. Chen Z, Siu B, Ho YS, Vincent R, Chua CC, Hamdy RC, and Chua BH. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol 30: 2281-2289, 1998.
30. Chung Y. Oxygen reperfusion is limited in the postischemic hypertrophic myocardium. Am J Physiol 290: H2075-H2084, 2006.
31. Clerk A, Fuller SJ, Michael A, and Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 273: 7228-7234, 1998.
32. Cohen MV, Yang XM, and Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74: 998-1004, 1994.
33. Datta SR, Brunet A, and Greenberg ME. Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
34. Dennis SC, Gevers W, and Opie LH. Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol 23:1077-1086, 1991.
35. Depre C, Vanoverschelde JL, Goudemant JF, Mottet I, and Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 92: 1911-1918, 1995.
36. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 280: H2649-H2657, 2001.
37. Dumont EA, Hofstra L, van Heerde WL, van den Eijnde S, Doevendans PA, DeMuinck E, Daemen MA, Smits JF, Frederik P, Wellens HJ, Daemen MJ, and Reutelingsperger CP. Cardiomyocyte death induced by myocardial ischemia and reperfusion: measurement with recombinant human annexin-V in a mouse model. Circulation 102: 1564-1568, 2000.
38. Dumont EA, Reutelingsperger CP, Smits JF, Daemen MJ, Doevendans PA, Wellens HJ, and Hofstra L. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart. Nat Med 7: 1352-1355, 2001.
39. Duncker DJ and Bache RJ. Inhibition of nitric oxide production aggravates myocardial hypoperfusion during exercise in the presence of a coronary artery stenosis. Circ Res 74: 629-640, 1994.
40. Duranteau J, Chandel NS, Kulisz A, Shao Z, and Schumacker PT. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes. J Biol Chem 273: 11619-11624, 1998.
41. Engelbrecht AM, Niesler C, Page C, and Lochner A. p38 and JNK have distinct regulatory functions on the development of apoptosis during simulated ischaemia and reperfusion in neonatal cardiomyocytes. Basic Res Cardiol 99: 338-350, 2004.
42. Ferrari R, Ceconi C, Curello S, Cargnoni A, Pasini E, and Visioli O. The occurrence of oxidative stress during reperfusion in experimental animals and men. Cardiovasc Drugs Ther 5(suppl 2): 277-287, 1991.
43. Fiorucci S, Mencarelli A, Mannucci R, Distrutti E, Morelli A, del Soldato P, and Moncada S. NCX-4016, a nitric oxide-releasing aspirin, protects endothelial cells against apoptosis by modulating mitochondrial function. FASEB J 16: 1645-1647, 2002.
44. Friedman BJ, Grinberg OY, Isaacs KA, Ruuge EK, and Swartz HM. Effect of repetitive ischemia on myocardial oxygen tension in isolated perfused and hypoperfused rat hearts. Magn Reson Med 35: 214-220, 1996.
45. Friedman BJ, Grinberg OY, Isaacs KA, Walczak TM, and Swartz HM. Myocardial oxygen tension and relative capillary density in isolated perfused rat hearts. J Mol Cell Cardiol 27: 2551-2558, 1995.
46. Fryer RM, Pratt PF, Hsu AK, and Gross GJ. Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection. J Pharmacol Exp Ther 296: 642-649, 2001.
47. Garlick PB, Davies MJ, Hearse DJ, and Slater TF. Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 61: 757-760, 1987.
48. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
49. Greenlund LJ, Deckwerth TL, and Johnson EM Jr. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron 14: 303-315, 1995.
50. Grill HP, Zweier JL, Kuppusamy P, Weisfeldt ML, and Flaherty JT. Direct measurement of myocardial free radical generation in an in vivo model: effects of postischemic reperfusion and treatment with human recombinant superoxide dismutase. J Am Coll Cardiol 20: 1604-1611, 1992.
51. Guidarelli A, Brambilla L, Clementi E, Sciorati C, and Cantoni O. Stimulation of oxygen consumption promotes mitochondrial calcium accumulation, a process associated with, and causally linked to, enhanced formation of tert-butylhydroperoxide-induced DNA single-strand breaks. Exp Cell Res 237: 176-185, 1997.
52. Halestrap AP, Clarke SJ, and Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion: a target for cardioprotection. Cardiovasc Res 61: 372-385, 2004.
53. Harabin AL, Braisted JC, and Flynn ET. Response of antioxidant enzymes to intermittent and continuous hyperbaric oxygen. J Appl Physiol 69: 328-335, 1990.
54. Hausenloy DJ, Maddock HL, Baxter GF, and Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? Cardiovasc Res 55: 534-543, 2002.
55. Hausenloy DJ, Tsang A, Mocanu MM, and Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288: H971-H976, 2005.
56. Hearse DJ and Bolli R. Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 26: 101-108, 1992.
57. Ihnken K, Morita K, Buckberg GD, and Young HH. Studies of hypoxemic/reoxygenation injury with aortic clamping, XI: cardiac advantages of normoxemic versus hyperoxemic management during cardiopulmonary bypass. J Thorac Cardiovasc Surg 110: 1255-1264, 1995.
58. Ihnken K, Winkler A, Schlensak C, Sarai K, Neidhart G, Unkelbach U, Mulsch A, and Sewell A. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg 116: 327-334, 1998.
59. Ilangovan G, Liebgott T, Kutala V K, Petryakov S, Zweier J L, and Kuppusamy P. EPR oximetry in the beating heart: myocardial oxygen consumption rate as an index of postischemic recovery. Magn Reson Med 51: 835-842, 2004.
60. Johnson G 3rd, Tsao PS, and Lefer AM. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion. Crit Care Med 19: 244-252, 1991.
61. Johnson LL, Schofield L, Bouchard M, Chaves L, Poppas A, Reinert S, Zalesky P, Creech J, and Williams DO. Hyperbaric oxygen solution infused into the anterior interventricular vein at reperfusion reduces infarct size in swine. Am J Physiol Heart Circ Physiol 287: H2234-H2240, 2004.
62. Johnston WE, Vinten-Johansen J, Shugart HE, and Santamore WP. Positive end-expiratory pressure potentiates the severity of canine right ventricular ischemia-reperfusion injury. Am J Physiol 262: H168-H176, 1992.
63. Jones SP, Greer JJ, Kakkar AK, Ware PD, Turnage RH, Hicks M, van Haperen R, de Crom R, Kawashima S, Yokoyama M, and Lefer DJ. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 286: H276-H282, 2004.
64. Jordan JE, Zhao ZQ, and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
65. Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, and Sollott SJ. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113: 1535-1549, 2004.
66. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107, 1996.
67. Kaneda T, Ku K, Inoue T, Onoe M, and Oku H. Postischemic reperfusion injury can be attenuated by oxygen tension control. Jpn Circ J 65: 213-218, 2001.
68. Kern KB, Hilwig RW, Rhee KH, and Berg RA. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 28: 232-240, 1996.
69. Khan M, Varadharaj S, Ganesan LP, Shobha JC, Naidu MU, Parinandi NL, Tridandapani S, Kutala VK, and Kuppusamy P. C-phycocyanin protects against ischemia-reperfusion injury of heart through involvement of p38 MAPK and ERK signaling. Am J Physiol Heart Circ Physiol 290: H2136-H2145, 2006.
70. Kim CH, Choi H, Chun YS, Kim GT, Park JW, and Kim MS. Hyperbaric oxygenation pretreatment induces catalase and reduces infarct size in ischemic rat myocardium. Pflugers Arch 442: 519-525, 2001.
71. Kim KB, Chung HH, Kim MS, and Rho JR. Changes in the antioxidative defensive system during open heart operations in humans. Ann Thorac Surg 58: 170-175, 1994.
72. Kim KS, Takeda K, Sethi R, Pracyk JB, Tanaka K, Zhou YF, Yu ZX, Ferrans VJ, Bruder JT, Kovesdi I, Irani K, Goldschmidt-Clermont P, and Finkel T. Protection from reoxygenation injury by inhibition of rac1. J Clin Invest 101: 1821-1826, 1998.
73. Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, Kerendi F, Guyton RA, and Vinten-Johansen J. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res 62: 74-85, 2004.
74. Kloner RA, Przyklenk K, and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues. Circulation 80: 1115-1127, 1989.
75. Kolodgie FD, Virmani R, and Farb A. Limitation of no reflow injury by blood-free reperfusion with oxygenated perfluorochemical (Fluosol-DA 20%). J Am Coll Cardiol 18: 215-223, 1991.
76. Koppenol WH. Peroxynitrite uncloaked? Chem Res Toxicol 11: 716-717, 1998.
77. Krijnen PA, Nijmeijer R, Meijer CJ, Visser CA, Hack CE, and Niessen HW. Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 55: 801-811, 2002.
78. Kukreja RC and Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 26: 641-655, 1992.
79. Kutala VK, Khan M, Mandal R, Ganesan LP, Tridandapani S, Kalai T, Hideg K, and Kuppusamy P. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties. J Pharmacol Exp Ther 317: 921-928, 2006.
80. Lefer AM. Attenuation of myocardial ischemia-reperfusion injury with nitric oxide replacement therapy. Ann Thorac Surg 60: 847-851, 1995.
81. Lefer AM and Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 32: 743-751, 1996.
82. Lefer AM, Tsao PS, Lefer DJ, and Ma XL. Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. FASEB J 5: 2029-2034, 1991.
83. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, and Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem 278: 8516-8525, 2003.
84. Liaudet L, Soriano FG, and Szabo C. Biology of nitric oxide signaling. Crit Care Med 28: N37-N52, 2000.
85. Lin KT, Xue JY, Sun FF, and Wong PY. Reactive oxygen species participate in peroxynitrite-induced apoptosis in HL-60 cells. Biochem Biophys Res Commun 230: 115-119, 1997.
86. Liu P, Hock CE, Nagele R, and Wong PY. Formation of nitric oxide, superoxide, and peroxynitrite in myocardial ischemia-reperfusion injury in rats. Am J Physiol 272: H2327-H2336, 1997.
87. Liu X, Chua CC, Gao J, Chen Z, Landy CL, Hamdy R, and Chua BH. Pifithrin-alpha protects against doxorubicin-induced apoptosis and acute cardiotoxicity in mice. Am J Physiol Heart Circ Physiol 286: H933-H939, 2004.
88. Liu Y and Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 263: H1107-H1112, 1992.
89. Lochner A, Marais E, Genade S, and Moolman J A. Nitric oxide: a trigger for classic preconditioning? Am J Physiol Heart Circ Physiol 279: H2752-H2765, 2000.
90. Lopez BL, Liu GL, Christopher TA, and Ma XL. Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron Artery Dis 8: 149-153, 1997.
91. Lounsbury KM, Hu Q, and Ziegelstein RC. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 28: 1362-1369, 2000.
92. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, and Yue TL. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99: 1685-1691, 1999.
93. Mackay K and Mochly-Rosen D. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia. J Biol Chem 274: 6272-6279, 1999.
94. Massoudy P, Mempel T, Raschke P, and Becker B F. Reduction of oxygen delivery during post-ischemic reperfusion protects the isolated guinea pig heart. Basic Res Cardiol 94: 231-237, 1999.
95. Maulik N, Yoshida T, and Das DK. Oxidative stress developed during the reperfusion of ischemic myocardium induces apoptosis. Free Radic Biol Med 24: 869-875, 1998.
96. Maxwell SR and Lip GY. Free radicals and antioxidants in cardiovascular disease. Br J Clin Pharmacol 44: 307-317, 1997.
97. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
98. Mehta JL, Nichols WW, and Mehta P. Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 11: 1309-1316, 1988.
99. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005-2015, 1993.
100. Moncada S and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012, 1993.
101. Muijsers RB, Folkerts G, Henricks PA, Sadeghi-Hashjin G, and Nijkamp FP. Peroxynitrite: a two-faced metabolite of nitric oxide. Life Sci 60: 1833-1845, 1997.
102. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
103. Nabel EG. CDKs and CKIs: molecular targets for tissue remodelling. Nat Rev Drug Discov 1: 587-598, 2002.
104. Nakanishi K, Zhao ZQ, Vinten-Johansen J, Hudspeth DA, McGee DS, and Hammon JW Jr. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction. J Thorac Cardiovasc Surg 109: 1146-1154, 1995.
105. Naseem SA, Kontos MC, Rao PS, Jesse RL, Hess ML, and Kukreja RC. Sustained inhibition of nitric oxide by NG-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 27: 419-426, 1995.
106. Neely JR and Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann Rev Physiol 36: 413-424, 1974.
107. Okamoto F, Allen BS, Buckberg GD, Bugyi H, and Leaf J. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion. J Thorac Cardiovasc Surg 92: 613-620, 1986.
108. Omura T, Yoshiyama M, Shimada T, Shimizu N, Kim S, Iwao H, Takeuchi K, and Yoshikawa J. Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats. J Mol Cell Cardiol 31: 1269-1279, 1999.
109. Padgaonkar VA, Giblin FJ, Fowler K, Leverenz VR, Reddan JR, and Dziedzic DC. Heme oxygenase synthesis is induced in cultured lens epithelium by hyperbaric oxygen or puromycin. Exp Eye Res 65: 435-443, 1997.
110. Pandian RP, Parinandi NL, Ilangovan G, Zweier JL, and Kuppusamy P. Novel particulate spin probe for targeted determination of oxygen in cells and tissues. Free Radic Biol Med 35: 1138-1148, 2003.
111. Paradies G, Petrosillo G, Pistolese M, and Ruggiero FM. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286: 135-141, 2002.
112. Park JR and Hockenbery DM. BCL-2, a novel regulator of apoptosis. J Cell Biochem 60: 12-17, 1996.
113. Parratt JR and Vegh A. Coronary vascular endothelium-myocyte interactions in protection of the heart by ischaemic preconditioning. J Physiol Pharmacol 50: 509-524, 1999.
114. Peng CF, Murphy ML, Colwell K, and Straub KD. Controlled versus hyperemic flow during reperfusion of jeopardized ischemic myocardium. Am Heart J 117: 515-522, 1989.
115. Pernow J and Wang QD. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury. Acta Physiol Scand 167: 151-159, 1999.
116. Petrosillo G, Di Venosa N, Ruggiero F M, Pistolese M, D'Agostino D, Tiravanti E, Fiore T, and Paradies G. Mitochondrial dysfunction associated with cardiac ischemia/reperfusion can be attenuated by oxygen tension control: role of oxygen-free radicals and cardiolipin. Biochim Biophys Acta 1710: 78-86, 2005.
117. Piper HM, Siegmund B, and Schluter KD. Prevention of the oxygen paradox in the isolated cardiomyocyte and the whole heart. Am J Cardiovasc Pathol 4: 115-122, 1992.
118. Pomposiello S, Yang XP, Liu YH, Surakanti M, Rhaleb NE, Sevilla M, and Carretero OA. Autacoids mediate coronary vasoconstriction induced by nitric oxide synthesis inhibition. J Cardiovasc Pharmacol 30: 599-606, 1997.
119. Prendergast BD, Sagach VF, and Shah AM. Basal release of nitric oxide augments the Frank-Starling response in the isolated heart. Circulation 96: 1320-1329, 1997.
120. Radi R, Rodriguez M, Castro L, and Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308: 89-95, 1994.
121. Rey FE, Li XC, Carretero OA, Garvin JL, and Pagano PJ. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox). Circulation 106: 2497-2502, 2002.
122. Roberts MJ, Young IS, Trouton TG, Trimble ER, Khan MM, Webb SW, Wilson CM, Patterson GC, and Adgey AA. Transient release of lipid peroxides after coronary artery balloon angioplasty. Lancet 336: 143-145, 1990.
123. Ronson RS, Nakamura M, and Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res 44: 47-59, 1999.
124. Rossoni G, Berti M, Colonna VD, Bernareggi M, Del Soldato P, and Berti F. Myocardial protection by the nitroderivative of aspirin, NCX 4016: in vitro and in vivo experiments in the rabbit. Ital Heart J 1: 146-155, 2000.
125. Rossoni G, Manfredi B, Colonna V D, Bernareggi M, and Berti F. The nitroderivative of aspirin, NCX 4016, reduces infarct size caused by myocardial ischemia-reperfusion in the anesthetized rat. J Pharmacol Exp Ther 297: 380-387, 2001.
126. Rothstein EC, Byron KL, Reed RE, Fliegel L, and Lucchesi PA. H(2)O(2)-induced Ca(2+) overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway. Am J Physiol Heart Circ Physiol 283: H598-H605, 2002.
127. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M, Pendyala S, Levy D, Sharma N, Venojarvi M, Strauch A, Orosz C G, and Sen CK. Oxygen sensing by primary cardiac fibroblasts: a key role of p21(Waf1/Cip1/Sdi1). Circ Res 92: 264-271, 2003.
128. Roy S, Khanna S, and Sen CK. Perceived hyperoxia: oxygen-regulated signal transduction pathways in the heart. Methods Enzymol 381: 133-139, 2004.
129. Roy S, Khanna S, Wallace WA, Lappalainen J, Rink C, Cardounel AJ, Zweier JL, and Sen CK. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J Biol Chem 278: 47129-47135, 2003.
130. Saikumar P, Dong Z, Weinberg JM, and Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 17: 3341-3349, 1998.
131. Sato H, Zhao ZQ, and Vinten-Johansen J. L-Arginine inhibits neutrophil adherence and coronary artery dysfunction. Cardiovasc Res 31: 63-72, 1996.
132. Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, and Marber MS. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J 14: 2237-2246, 2000.
133. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R, and Latchman D. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/ reperfusion injury. Circulation 104: 253-256, 2001.
134. Sen CK, Khanna S, and Roy S. Perceived hyperoxia: oxygen-induced remodeling of the reoxygenated heart. Cardiovasc Res 71: 280-288, 2006.
135. Serviddio G, Di Venosa N, Federici A, D'Agostino D, Rollo T, Prigigallo F, Altomare E, Fiore T, and Vendemiale G. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxide production and glutathione depletion. FASEB J 19: 354-361, 2005.
136. Shandling AH, Ellestad MH, Hart GB, Crump R, Marlow D, Van Natta B, Messenger JC, Strauss M, and Stavitsky Y. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" pilot study. Am Heart J 134: 544-550, 1997.
137. Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, Takeuchi K, Iwao H, and Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res 38: 116-124, 1998.
138. Shinmura K, Tang XL, Takano H, Hill M, and Bolli R. Nitric oxide donors attenuate myocardial stunning in conscious rabbits. Am J Physiol 277: H2495-H2503, 1999.
139. Spears JR, Henney C, Prcevski P, Xu R, Li L, Brereton GJ, DiCarli M, Spanta A, Crilly R, Sulaiman AM, Hadeed S, Lavine S, Patterson WR, Creech J, and Vander Heide R. Aqueous oxygen hyperbaric reperfusion in a porcine model of myocardial infarction. J Invasive Cardiol 14: 160-166, 2002.
140. Stavitsky Y, Shandling AH, Ellestad MH, Hart GB, Van Natta B, Messenger JC, Strauss M, Dekleva MN, Alexander JM, Mattice M, and Clarke D. Hyperbaric oxygen and thrombolysis in myocardial infarction: the "HOT MI" randomized multicenter study. Cardiology 90: 131-136, 1998.
141. Stephanou A, Scarabelli TM, Townsend PA, Bell R, Yellon D, Knight RA, and Latchman DS. The carboxyl-terminal activation domain of the STAT-1 transcription factor enhances ischemia/reperfusion-induced apoptosis in cardiac myocytes. FASEB J 16: 1841-1843, 2002.
142. Sterling DL, Thornton JD, Swafford A, Gottlieb SF, Bishop SP, Stanley AW, and Downey JM. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo. Circulation 88: 1931-1936, 1993.
143. Strohm C, Barancik T, Bruhl ML, Kilian SA, and Schaper W. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 36: 218-229, 2000.
144. Sumida T, Otani H, Kyoi S, Okada T, Fujiwara H, Nakao Y, Kido M, and Imamura H. Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580. Am J Physiol Heart Circ Physiol 288: H2726-H2734, 2005.
145. Sun HY, Wang NP, Halkos ME, Kerendi F, Kin H, Wang RX, Guyton RA, and Zhao ZQ. Involvement of Na+/H+ exchanger in hypoxia/re-oxygenation-induced neonatal rat cardiomyocyte apoptosis. Eur J Pharmacol 486: 121-131, 2004.
146. Sunami K, Takeda Y, Hashimoto M, and Hirakawa M. Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med 28: 2831-2836, 2000.
147. Swartz HM, Boyer S, Brown D, Chang K, Cast P, Glockner JF, Hu H, Liu KJ, Moussavi M, Nilges M, and et al. The use of EPR for the measurement of the concentration of oxygen in vivo in tissues under physiologically pertinent conditions and concentrations. Adv Exp Med Biol 317: 221-228, 1992.
148. Szekeres M, Dezsi L, Monos E, and Metsa-Ketela T. Effect of a new nitric oxide donor on the biomechanical performance of the isolated ischaemic rat heart. Acta Physiol Scand 161: 55-61, 1997.
149. Takada Y, Hashimoto M, Kasahara J, Aihara K, and Fukunaga K. Cytoprotective effect of sodium orthovanadate on ischemia/reperfusion-induced injury in the rat heart involves Akt activation and inhibition of fodrin breakdown and apoptosis. J Pharmacol Exp Ther 311: 1249-1255, 2004.
150. Thompson-Gorman SL and Zweier JL. Evaluation of the role of xanthine oxidase in myocardial reperfusion injury. J Biol Chem 265: 6656-6663, 1990.
151. Toth A, Halmosi R, Kovacs K, Deres P, Kalai T, Hideg K, Toth K, and Sumegi B. Akt activation induced by an antioxidant compound during ischemia-reperfusion. Free Radic Biol Med 35: 1051-1063, 2003.
152. Toufektsian MC, Boucher F, Pucheu S, Tanguy S, Ribuot C, Sanou D, Tresallet N, and de Leiris J. Effects of selenium deficiency on the response of cardiac tissue to ischemia and reperfusion. Toxicology 148: 125-132, 2000.
153. Vergroesen I, Noble MIM, Wieringa PA, and Spaan JAE. Quantification of O2 consumption and arterial pressure as independent determinants of coronary flow. Am J Physiol 262: H5435-H5553, 1987.
154. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61: 481-497, 2004.
155. Vinten-Johansen J. Postischemic ventricular performance and oxygen metabolism: corroboration or quandary? J Thorac Cardiovasc Surg 94: 639-641, 1987.
156. Wainwright CL, Miller AM, Work LM, and Del Soldato P. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. Br J Pharmacol 135: 1882-1888, 2002.
157. Wang P and Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart: evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem 271: 29223-29230, 1996.
158. Weyrich AS, Ma XL, and Lefer AM. The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 86: 279-288, 1992.
159. Woolfson RG, Patel VC, Neild GH, and Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551, 1995.
160. Yasmin W, Strynadka KD, and Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res 33: 422-432, 1997.
161. Yue TL, Ma XL, Wang X, Romanic AM, Liu GL, Louden C, Gu JL, Kumar S, Poste G, Ruffolo RR Jr, and Feuerstein GZ. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in
162. Zhang Y, Davies LR, Martin SM, Bawaney IM, Buettner GR, and Kerber RE. Magnesium reduces free radical concentration and preserves left ventricular function after direct current shocks. Resuscitation 56: 199-206, 2003.
163. Zhao X, He G, Chen YR, Pandian RP, Kuppusamy P, and Zweier JL. Endothelium-derived nitric oxide regulates postischemic myocardial oxygenation and oxygen consumption by modulation of mitochondrial electron transport. Circulation 111: 2966-2972, 2005.
164. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, and Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285: H579-H588, 2003.
165. Zhao ZQ, Nakamura M, Wang NP, Wilcox JN, Shearer S, Ronson RS, Guyton RA, and Vinten-Johansen J. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 45: 651-660, 2000.
166. Zou Y, Zhu W, Sakamoto M, Qin Y, Akazawa H, Toko H, Mizukami M, Takeda N, Minamino T, Takano H, Nagai T, Nakai A, and Komuro I. Heat shock transcription factor 1 protects cardiomyocytes from ischemia/reperfusion injury. Circulation 108: 3024-3030, 2003.
167. Zweier JL, Duke SS, Kuppusamy P, Sylvester JT, and Gabrielson EW. Electron paramagnetic resonance evidence that cellular oxygen toxicity is caused by the generation of superoxide and hydroxyl free radicals. FEBS Lett 252: 12-16, 1989.
168. Zweier JL and Kuppusamy P. Electron paramagnetic resonance measurements of free radicals in the intact beating heart: a technique for detection and characterization of free radicals in whole biological tissues. Proc Natl Acad Sci U S A 85: 5703-5707, 1988.
169. Zweier JL, Kuppusamy P, Thompson-Gorman S, Klunk D, and Lutty GA. Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol 266: C700-C708, 1994.
170. Zweier JL, Kuppusamy P, Williams R, Rayburn BK, Smith D, Weisfeldt ML, and Flaherty JT. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem 264: 18890-18895, 1989.
171. Zweier JL, Thompson-Gorman S, and Kuppusamy P. Measurement of oxygen concentrations in the intact beating heart using electron paramagnetic resonance spectroscopy: a technique for measuring oxygen concentrations in situ. J Bioenerg Biomembr 23: 855-871, 1991.
172. Zweier JL, Wang P, and Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 270: 304-307, 1995.